Global Protein Therapeutics Market Assessment 2020-2025 - Outbreak of COVID-19 Providing Growth Opportunities, Development of Novel Recombinant Proteins Driving Growth
November 16, 2020 13:48 ET
|
Research and Markets
Dublin, Nov. 16, 2020 (GLOBE NEWSWIRE) -- The "Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
Protein Therapeutics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2012–2022
November 20, 2017 01:10 ET
|
Crystal Market Research
LAS VEGAS, Nov. 20, 2017 (GLOBE NEWSWIRE) -- The Protein Therapeutics Market was worth USD 123.54 billion in the year of 2012 and is expected to reach approximately USD 241 billion by 2022, while...
iBio Receives US and European Patents for Protein Expression Technology
February 12, 2015 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Feb 12, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issuance of...
iBio Adds to iBioModulator Portfolio and Product Pipeline
February 04, 2015 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Feb 4, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issue of a new...
iBio Provides Updates on Its IBIO-CFB03 Fibrosis Drug Candidate and Other Activities for the 2014 Annual Shareholders Meeting
December 10, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Dec 10, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in biotechnology for developing and manufacturing plant-made pharmaceutical products, will provide shareholders and...
iBio Grants Caliber License for Production of Antibodies Targeting Ebola
November 10, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Nov 10, 2014) - iBio, Inc. (NYSE MKT: IBIO) and Caliber Biotherapeutics LLC executed an agreement, effective today, for an emergency use license to the iBioLaunch™...
iBio Expands Exclusive Product Collaboration With Novici Biotech
October 22, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Oct 22, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, and Novici Biotech LLC...
iBio Responds to Inquiries About its Role in Emergency Response to Ebola Virus Disease Outbreak
October 16, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Oct 16, 2014) - iBio, Inc. (NYSE MKT: IBIO) today confirmed, in response to shareholder and media inquiries: (i) the applicability of its issued U.S. iBioLaunch™...
iBio Reports on Filing of 2014 Annual Report
October 03, 2014 17:00 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Oct 3, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced, as required...
Dr. Thomas A. Medsger Jr. Joins iBio Clinical Advisory Board
September 02, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Sep 2, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of biotechnology for developing and manufacturing plant-made pharmaceutical products, has appointed Thomas...